Cargando…

Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation

Detalles Bibliográficos
Autores principales:	Patti, Giuseppe, Wang, Rosa, Marston, Xiaocong Li, Yeh, Yu-Chen, Zimmermann, Lisa, Ye, Xin, Gao, Xin, Brüggenjürgen, Bernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423184/ https://www.ncbi.nlm.nih.gov/pubmed/37462897 http://dx.doi.org/10.1007/s40119-023-00321-w

Ejemplares similares

Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation
por: Cavallari, Ilaria, et al.
Publicado: (2018)

Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study
por: Banerjee, Amitava, et al.
Publicado: (2020)

Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
por: Farinha, José Maria, et al.
Publicado: (2022)

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2022)

Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
por: Song, Ting, et al.
Publicado: (2021)

Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation
por: Jankowska-Polańska, Beata, et al.
Publicado: (2016)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation
por: Paquette, Miney, et al.
Publicado: (2020)

Correction to: The impact on renal function after longterm use of anticoagulants in atrial fibrillation patients
por: Lee, Wei-Chieh, et al.
Publicado: (2021)

Correction: Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
por: de Jong, Lisa A., et al.
Publicado: (2022)

The importance of adherence and persistence in the elderly atrial fibrillation patient
por: Hylek, Elaine M
Publicado: (2020)

Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
por: Zhou, Meijia, et al.
Publicado: (2015)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Ablation of Left Atrial Tachycardia following Catheter Ablation of Atrial Fibrillation: 12-Month Success Rates
por: Luik, Armin, et al.
Publicado: (2022)

Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal
por: Lowres, Nicole, et al.
Publicado: (2019)

Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
por: Komen, Joris J, et al.
Publicado: (2020)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
Publicado: (2020)

Correction to: Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status
por: Varona, José Felipe, et al.
Publicado: (2021)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation
por: Yang, Lanting, et al.
Publicado: (2021)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
por: Pundi, Krishna N., et al.
Publicado: (2021)

Erratum to: Long-term adherence and persistence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
Publicado: (2021)

Persistent atrial fibrillation is not associated with thrombomodulin level increase in efficiently anticoagulated patients
por: Wożakowska-Kapłon, Beata, et al.
Publicado: (2010)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
por: Zielinski, Gilda Denise, et al.
Publicado: (2019)

Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Publicado: (2018)

Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries
por: Komen, Joris J, et al.
Publicado: (2021)

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
por: Hernandez, Inmaculada, et al.
Publicado: (2019)

Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
por: Yu, Hee Tae, et al.
Publicado: (2020)

Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
por: Zielinski, Gilda D., et al.
Publicado: (2021)

Adherence with direct oral anticoagulants in patients with atrial fibrillation: Trends, risk factors, and outcomes
por: Arbel, Anat, et al.
Publicado: (2021)

Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation
por: Rymer, Jennifer A., et al.
Publicado: (2023)

Shared decision making for anticoagulation reduces anxiety and improves adherence in patients with atrial fibrillation
por: Chiu, Hsiao-Hui, et al.
Publicado: (2023)

Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
por: Dhamane, Amol D, et al.
Publicado: (2021)

Correction: Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
Publicado: (2019)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Non–Vitamin K Antagonist Oral Anticoagulants and Factors Influencing the Ischemic and Bleeding Risk in Elderly Patients With Atrial Fibrillation: A Review of Current Evidence
por: Patti, Giuseppe, et al.
Publicado: (2021)

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cun5mdrp38s901nr2ahlg1o9kj